[{"Assets_0_Q1_USD":"23854700000.0","CIK":"875045","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"2.7","EarningsPerShareDiluted_1_Q1_USD":"2.69","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"32775642095.0","MinorityInterest_0_Q1_USD":"-19000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"769000000.0","NetIncomeLoss_1_Q1_USD":"410200000.0","OfficialName":"Biogen Inc. Common Stock","ProfitLoss_1_Q1_USD":"404600000.0","RevenuesConverted_1_Q1_USD":"2694000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"10663200000.0","StockholdersEquity_0_Q1_USD":"10682200000.0","Ticker":"BIIB","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"152300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"151900000.0","filed":"20210422","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"BIOGEN INC.","period":"20210331","qtrs":"1","uom":"USD"}]